Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2005;96:e35-e47
Published online before print February 24, 2005, doi: 10.1161/01.RES.0000160709.49633.2b
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
96/5/e35    most recent
01.RES.0000160709.49633.2bv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kneller*, J.
Right arrow Articles by Jalife, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kneller*, J.
Right arrow Articles by Jalife, J.
Related Collections
Right arrow Animal models of human disease
Right arrow Arrhythmias, clinical electrophysiology, drugs
(Circulation Research. 2005;96:e35.)
© 2005 American Heart Association, Inc.


UltraRapid Communications

Mechanisms of Atrial Fibrillation Termination by Pure Sodium Channel Blockade in an Ionically-Realistic Mathematical Model

James Kneller*, Jérôme Kalifa*, Renqiang Zou, Alexey V. Zaitsev, Mark Warren, Omer Berenfeld, Edward J. Vigmond, L. Joshua Leon, Stanley Nattel, José Jalife

From the Research Center and Department of Medicine, Montreal Heart Institute and University of Montreal (J. Kneller, R.Z., S.N.); the Department of Pharmacology, McGill University (S.N.), Montreal, Quebec, Canada; the Department of Pharmacology and Institute for Cardiovascular Research, SUNY Upstate Medical University (J. Kalifa, A.V.Z., M.W., O.B., J.J.); Syracuse, NY; and the Department of Electrical and Computer Engineering (E.J.V., L.J.L), University of Calgary, Alberta, Canada.

Correspondence to Dr Stanley Nattel, Research Center, Montreal Heart Institute, 5000 Belanger St E, Montreal, Quebec, Canada, H1T 1C8. E-mail stanley.nattel{at}icm-mhi.org

The mechanisms by which Na+-channel blocking antiarrhythmic drugs terminate atrial fibrillation (AF) remain unclear. Classical "leading-circle" theory suggests that Na+-channel blockade should, if anything, promote re-entry. We used an ionically-based mathematical model of vagotonic AF to evaluate the effects of applying pure Na+-current (INa) inhibition during sustained arrhythmia. Under control conditions, AF was maintained by 1 or 2 dominant spiral waves, with fibrillatory propagation at critical levels of action potential duration (APD) dispersion. INa inhibition terminated AF increasingly with increasing block, terminating all AF at 65% block. During 1:1 conduction, INa inhibition reduced APD (by 13% at 4 Hz and 60% block), conduction velocity (by 37%), and re-entry wavelength (by 24%). During AF, INa inhibition increased the size of primary rotors and reduced re-entry rate (eg, dominant frequency decreased by 33% at 60% INa inhibition) while decreasing generation of secondary wavelets by wavebreak. Three mechanisms contributed to INa block–induced AF termination in the model: (1) enlargement of the center of rotation beyond the capacity of the computational substrate; (2) decreased anchoring to functional obstacles, increasing meander and extinction at boundaries; and (3) reduction in the number of secondary wavelets that could provide new primary rotors. Optical mapping in isolated sheep hearts confirmed that tetrodotoxin dose-dependently terminates AF while producing effects qualitatively like those of INa inhibition in the mathematical model. We conclude that pure INa inhibition terminates AF, producing activation changes consistent with previous clinical and experimental observations. These results provide insights into previously enigmatic mechanisms of class I antiarrhythmic drug-induced AF termination. The full text of this article is available online at http://circres.ahajournals.org


Key Words: atrial fibrillation • mathematical model • class I drugs • sodium channels




This article has been cited by other articles:


Home page
EuropaceHome page
J. Tuan, F. Osman, M. Jeilan, S. Kundu, R. Mantravadi, P. J. Stafford, and G. A. Ng
Increase in organization index predicts atrial fibrillation termination with flecainide post-ablation: spectral analysis of intracardiac electrograms
Europace, December 17, 2009; (2009) eup405v1.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Comtois, M. Sakabe, E. J. Vigmond, M. Munoz, A. Texier, A. Shiroshita-Takeshita, and S. Nattel
Mechanisms of atrial fibrillation termination by rapidly unbinding Na+ channel blockers: insights from mathematical models and experimental correlates
Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1489 - H1504.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. R. Ehrlich, P. Biliczki, S. H. Hohnloser, and S. Nattel
Atrial-Selective Approaches for the Treatment of Atrial Fibrillation
J. Am. Coll. Cardiol., February 26, 2008; 51(8): 787 - 792.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
B. London, C. Albert, M. E. Anderson, W. R. Giles, D. R. Van Wagoner, E. Balk, G. E. Billman, M. Chung, W. Lands, A. Leaf, et al.
Omega-3 Fatty Acids and Cardiac Arrhythmias: Prior Studies and Recommendations for Future Research: A Report from the National Heart, Lung, and Blood Institute and Office of Dietary Supplements Omega-3 Fatty Acids and Their Role in Cardiac Arrhythmogenesis Workshop
Circulation, September 4, 2007; 116(10): e320 - e335.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
P. Ruchat, L. Dang, J. Schlaepfer, N. Virag, L. K. von Segesser, and L. Kappenberger
Use of a biophysical model of atrial fibrillation in the interpretation of the outcome of surgical ablation procedures
Eur. J. Cardiothorac. Surg., July 1, 2007; 32(1): 90 - 95.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
P. Ruchat, L. Dang, N. Virag, J. Schlaepfer, L. K. von Segesser, and L. Kappenberger
A biophysical model of atrial fibrillation to define the appropriate ablation pattern in modified maze
Eur. J. Cardiothorac. Surg., January 1, 2007; 31(1): 65 - 69.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Z. Y. Lim, B. Maskara, F. Aguel, R. Emokpae Jr, and L. Tung
Spiral Wave Attachment to Millimeter-Sized Obstacles
Circulation, November 14, 2006; 114(20): 2113 - 2121.
[Abstract] [Full Text] [PDF]


Home page
Phil Trans R Soc AHome page
S. R Kuo and N. A Trayanova
Action potential morphology heterogeneity in the atrium and its effect on atrial reentry: a two-dimensional and quasi-three-dimensional study
Phil Trans R Soc A, June 15, 2006; 364(1843): 1349 - 1366.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. Zou, J. Kneller, L. J. Leon, and S. Nattel
Substrate size as a determinant of fibrillatory activity maintenance in a mathematical model of canine atrium
Am J Physiol Heart Circ Physiol, September 1, 2005; 289(3): H1002 - H1012.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
P. Comtois, J. Kneller, and S. Nattel
Of circles and spirals: Bridging the gap between the leading circle and spiral wave concepts of cardiac reentry
Europace, January 1, 2005; 7(s2): S10 - S20.
[Abstract] [Full Text] [PDF]